{"id":"W4392130094","doi":"10.1007/s12325-024-02797-x","title":"Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cilag; Janssen Research and Development; Genentech; Chugai Pharmaceutical; EUSA Pharma; Servier; Incyte; bluebird bio; Regeneron Pharmaceuticals; Universidad de Salamanca; Adaptive Biotechnologies; Karyopharm Therapeutics; Legend Biotech; Celgene; Cerecor; Janssen Pharmaceuticals; Yale University; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Hazard ratio; Confidence interval; Relative risk; Refractory (planetary science); Proportional hazards model; Multiple myeloma; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005388006,0.0005536859,0.001386746,0.0004622164,0.0002430801,0.0009646464,0.0006219969,0.0007693421,0.001774254],"category_scores_gemma":[0.004151993,0.0002261312,0.002094551,0.0005091424,0.0005060423,0.0006615102,0.0005717155,0.0007841061,0.0001946937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009960192,"about_ca_system_score_gemma":0.0005363766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006299783,"about_ca_topic_score_gemma":0.00107623,"domain_scores_codex":[0.9976109,0.001620247,0.0001950546,0.000286327,0.0001644329,0.0001229992],"domain_scores_gemma":[0.997385,0.0009149903,0.0008977781,0.0002677375,0.0001699352,0.000364552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9321881,0.002543623,0.0194116,0.0007599323,0.004077948,0.00004663596,0.0001759821,0.0006723955,0.00273842,0.0001851225,0.0002616256,0.03693856],"study_design_scores_gemma":[0.2675049,0.5194126,0.1865149,0.0003425371,0.01315444,0.0003018486,0.0003577499,0.002780011,0.002921753,0.0005258503,0.006066606,0.0001166462],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926791,0.005736138,0.0002081581,0.0001283923,0.00004382644,0.0001961099,0.0003059606,0.000009245247,0.0006930673],"genre_scores_gemma":[0.9977059,0.0009939962,0.0002009015,0.0001248196,0.00005800383,0.0001818157,0.0004938504,0.000002521579,0.0002382095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005388006,"threshold_uncertainty_score":0.02849483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05978296233205799,"score_gpt":0.3848374014435362,"score_spread":0.3250544391114782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}